- Lobbying
- Lobbying by BIOTECHNOLOGY INDUSTRY ORGANIZATION
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
James T. Walsh | U. S. Congressman |
Daniel Ritter | Counsel, Sen Subcom on Educ, Arts & Humanities |
Michael Evans | Tax Counsel/LD, Sen Baucus; Dem Chief Counsel, Sen Comm on Envt & Public Works; Chief Counsel, Sen Finance Comm |
Bart Gordon | U. S. Congressman [Lobbies Administration Only] |
Amy Flachbart | Chief of Staff, Rep. George Nethercutt |
Tim Punke | Chief Int'l Trade Counsel for Senate Fin. Comm. |
Scott Aliferis | n/a |
James Rogan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Registration
Issue(s) they said they’d lobby about: Pursue federal investment in basic applied research to benefit biotechnology..
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Pursue federal investment in basic applied research to benefit biotechnology..
Registration
Issue(s) they said they’d lobby about: Proposals to change the patent continuation practice, international intellectual property rules and the importance of intellectual property rights to biotechnology innovation..
Registration
Issue(s) they said they’d lobby about: Proposals to change the patent continuation practice, international intellectual property rules and the importance of intellectual property rights to biotechnology innovation..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate